Zhengye Biotechnology Holding Limited Ordinary Shares Stock Prediction and Forecast [ZYBT]

AI-generated source summary

The analysis is on Zhengye Biotechnology Holding (ZYBT). It was published on September 18, 2025. It has ranked ZYBT as a buy candidate, with a score of 2.43. Since August 22, those who followed the analysis would have enjoyed an impressive gain of 35.67%. The target is 9.50 and the analysis suggests the current price is undervalued. Resistance is found at 9.81 and support at 8.07. Volume fell along with the price during the last trading day, which is technically positive, given this stocks volatility. Analysts suggest a stop loss at $8.91, 5.96% below the current price. On Friday, September 19th, ZYBT Ordinary Shares are expected to open up $0.0317 and start trading at $9.50.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   19 Sept 2025, 03:59 UTC

   The analyst published the original source item.

2. First prediction resolved

   19 Sept 2025, 13:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   19 Sept 2025, 13:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:15 UTC

   Tahlil Plus began monitoring the extracted predictions.